Israel’s Biolojic Design (see here previously) is partnering Merck, to develop molecules that could be the basis for therapies to treat cancer and other immunological disorders. The venture is potentially worth up to 350 million euros to the Israeli company. … Continue reading →

Israel’s Bar-Ilan Prof. Yanay Ofran has invented antibodies to attack tumors, using computers and then produced them from amino acids in a process akin to 3D printing. His startup Biolojic Design created Aulos Bioscience which is conducting human trials of … Continue reading →

Israel’s Biolojic Design is developing an AI platform to generate antibodies that have specific targets and biological effects. It instructs the immune system to precisely attack the causes of disease, such as the mechanism underlying autoimmune disease, cancer or diabetes. … Continue reading →

Treatment for asthma. (TY Atid-EDI) Israel’s Teva has bought the rights to complete the development of BD9 – an antibody-based therapy for the treatment of asthma and atopic dermatitis from Israel’s Biolojic Design (see here previously). Biolojic’s AI platform generates … Continue reading →